One year monitoring of children with bronchial asthma and other allergic diseases treated with inhaled corticosteroids vs cromoglycates with serum ECP (S-ECP), FEV1, total IgE and blood eosinophil count - the influence of different therapy

M. Zapalka, F. Kopriva, J. Szotkowska (Olomouc, Czech Republic)

Source: Annual Congress 2002 - Updates of inhalation therapy in children
Session: Updates of inhalation therapy in children
Session type: Poster Discussion
Number: 2740
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Zapalka, F. Kopriva, J. Szotkowska (Olomouc, Czech Republic). One year monitoring of children with bronchial asthma and other allergic diseases treated with inhaled corticosteroids vs cromoglycates with serum ECP (S-ECP), FEV1, total IgE and blood eosinophil count - the influence of different therapy. Eur Respir J 2002; 20: Suppl. 38, 2740

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The value of the serum ECP (eosinophil cationic protein) level for monitoring the treatment of allergic bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 268s
Year: 2001

Ciclesonide 80 μg once daily reduces early and late asthmatic reaction, sputum eosinophils and serum ECP in asthma patients challenged with allergens
Source: Eur Respir J 2005; 26: Suppl. 49, 254s
Year: 2005

Minimal effect of inhaled corticosteroids (ICS) on blood eosinophil count in steroid-naïve COPD patients
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015


Sputum eosinophil counts in a large population of mild-to-moderate asthmatics: distribution, relationship with methacholine bronchial responsiveness and influence of a regular treatment with low doses of inhaled corticosteroids
Source: Eur Respir J 2001; 18: Suppl. 33, 531s
Year: 2001

Association between blood eosinophil count and exacerbation risk in patients with asthma receiving medium- or high-dosage inhaled corticosteroids
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017


Regular salbutamol use increases CXCL8 responses in asthma: relationship to the eosinophil response
Source: Eur Respir J 2003; 22: 118-126
Year: 2003



Does sputum eosinophil counts predict the response to inhaled corticosteroids in terms of methacholine bronchial responsiveness in steroid naive asthmatics?
Source: Eur Respir J 2001; 18: Suppl. 33, 336s
Year: 2001

Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids
Source: Eur Respir J 2002; 20: 1364-1369
Year: 2002



Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study
Source: Eur Respir J, 51 (5) 1702523; 10.1183/13993003.02523-2017
Year: 2018



Does eosinophil cationic protein (ECP) predict asthma outcome and response to treatment in asthmatic patients?
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012

Late Breaking Abstract - Blood eosinophil count (EOS) can accurately predict responsiveness to inhaled corticosteroids (ICS) in COPD, but only if measured while patients are not receiving steroids.
Source: International Congress 2018 – COPD: from LABA/ICS to LABA/LAMA/ICS
Year: 2018




Effect of IgE sensitization and allergen exposure on exhaled NO during inhaled corticosteroid (ICS) treatment in patients with asthma
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007


Correlation between specific serum IgE and exhaled NO levels at low and high inhaled corticosteroid use in allergic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 276s
Year: 2005

The effects of inhaled steroids, leukotriene receptor antagonists and theophylline on induced sputum cell counts, serum and sputum ECP levels in mild persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 261s
Year: 2001

High sputum eosinophils are associated with better response to inhaled corticosteroids in asthmatic patients
Source: Eur Respir J 2002; 20: Suppl. 38, 113s
Year: 2002

Omalizumab reduces asthma exacerbations in children (6–<12 years) with moderate-to-severe allergic (IgE-mediated) asthma irrespective of baseline LABA use
Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues
Year: 2009

Correlation of plasma IL-5 with sputum and blood eosinophils and ECP following a single nasal allergen challenge in non-asthmatic subjects with seasonal allergic rhinitis
Source: Eur Respir J 2002; 20: Suppl. 38, 217s
Year: 2002

Pharmacodynamic effect of benralizumab on blood basophils and serum biomarkers in adults with COPD with sputum eosinophilia
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015

Correlation between ECP in induced sputum and asthma symptoms in children treated with budesonide
Source: Eur Respir J 2001; 18: Suppl. 33, 450s
Year: 2001

eNO, ECP and bronchial hyperresponsiveness in mild asthmatic children out of therapy
Source: Eur Respir J 2005; 26: Suppl. 49, 42s
Year: 2005